# FDA recall D-0476-2024

> **Imprimis NJOF, LLC** · Class II · drug recall initiated 2024-04-10.

## Product

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08

## Reason for recall

Subpotent Drug

## Distribution

U.S. Nationwide

## Key facts

- **Recall number:** D-0476-2024
- **Recalling firm:** Imprimis NJOF, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-04-10
- **Report date:** 2024-05-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ledgewood, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0476-2024

## Citation

> AI Analytics. FDA recall D-0476-2024. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0476-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*